This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

BlackBerry Lands in Corporate Hospice

By: Herb Greenberg | 09/23/13 - 10:28 AM EDT

(Originally published on Real Money's Columnist Conversation.)

NEW YORK (TheStreet) -- The latest spin on BlackBerry (BBRY) is that it will re-focus on services in a last-ditch effort to survive.

Reality: All the king's horses and all the king's men cannot do much but watch BlackBerry whither in hospice for disrupted corporations. The goal of focusing on corporations simply will do little more than paper over the BlackBerry's rapid decline.

This story in the WSJ put it best: Even corporations and institutions are seeing users flee when they have a choice.

The reason: BlackBerry simply isn't that much fun or cutting edge. And besides, most employees don't want to lug around two phones. Even the keyboard isn't that much of a competitive edge, anymore. The new Apple (AAPL) operating system, for iPhone users, has corrected a significant issue regarding the accuracy of mis-typing on its keyboard.

BlackBerry's lag in creating a fast browser caused many to defect; once you defect, you don't return.

And beware of this line from the WSJ's piece:

"On Friday, BlackBerry said it would pull out of the consumer market and focus instead on its core business and on professional customers. They "helped build BlackBerry into the leading brand today for enterprise security, manageability and reliability," Chief Executive Thorsten Heins said."

I was in Heins' first meeting with the press after he took over the company's reins. At the time he was just as confident about why BlackBerry would succeed with consumers.

Time to move on...

P.S.: As I tweeted this morning, Mike Lazaridis waging a bid for BlackBerry would be like Antonio Perez trying to take over/save Kodak.

--Written by Herb Greenberg.

Herb Greenberg, editor of Herb Greenberg's Reality Check, is a contributor to CNBC. He does not own shares, short or trade shares in an individual corporate security.

Other Posts In Herb's A Dose of Reality:

Get More Investment Ideas:

To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.

Markets

DOW 17,083.80 -2.83 -0.02%
S&P 500 1,987.98 +0.97 0.05%
NASDAQ 4,472.1080 -1.5890 -0.04%

Herb's Tweets

Brokerage Partners

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs